Intravenous Nitroglycerin Titration for Blood Pressure Control
The initial recommended dose of intravenous nitroglycerin is 10-20 mcg/min, increased in increments of 5-10 mcg/min every 3-5 minutes as needed for blood pressure control, with careful monitoring to avoid large drops in systolic blood pressure. 1
Initial Preparation
- Each nitroglycerin vial (25 mg) should be diluted in 250 mL of either Dextrose (5%) Injection or Sodium Chloride (0.9%) Injection to yield a final concentration of 100 mcg/mL 2
- Alternative dilution: 25 mg nitroglycerin into 500 mL will yield a final concentration of 50 mcg/mL 2
- Use non-absorbing (non-PVC) tubing to ensure accurate dosing, as PVC tubing absorbs nitroglycerin 2
- Invert the parenteral bottle several times to ensure uniform dilution 2
Titration Protocol
Starting dose:
Titration increments:
- Initial titration: Increase by 5 mcg/min every 3-5 minutes until response is noted 2
- If no response at 20 mcg/min: Increase by 10 mcg/min increments 2
- For continued non-response: Increase by 20 mcg/min increments 2
- Once partial response is observed: Reduce increment size and extend interval between increases 2
Target parameters:
Monitoring Requirements
- Continuous blood pressure monitoring is essential 1
- For borderline blood pressures, arterial line placement facilitates titration 1
- Monitor heart rate (avoid increases >10 beats/min or rates >110 beats/min) 4
- For patients with heart failure, monitor for signs of improved cardiac output 1
Dose Adjustments
- After initial titration, concentration may be increased to limit fluid administration 2
- Do not exceed concentration of 400 mcg/mL 2
- If changing concentration, flush or replace the infusion set to ensure accurate dosing 2
- For prolonged infusions (>24-48 hours), higher doses may be needed due to tachyphylaxis 1, 5
- If doses >200 μg/min are required, consider alternative vasodilators 4, 2
Special Considerations
- Hypersensitive patients (e.g., angina without complications) may respond fully to doses as small as 5 mcg/min 2
- Use with extreme caution in patients with right ventricular infarction 1, 4
- Avoid in patients with systolic BP <90 mmHg 1
- Avoid in patients who have recently taken phosphodiesterase inhibitors (within 24-48 hours) 1, 4
- Common side effects include headache and hypotension 1, 4
Discontinuation
- Effects are spontaneously reversible within approximately 27 minutes after stopping infusion 5
- When symptoms are controlled, consider transitioning to non-parenteral nitrate alternatives with appropriate nitrate-free intervals 4
This titration protocol ensures safe and effective use of intravenous nitroglycerin for blood pressure control while minimizing the risk of excessive hypotension that could compromise organ perfusion.